Document:

Exhibit 10.2 Retention and Transaction Award Plan

Exhibit 10.2

Signature Office REIT, Inc.
Retention and Transaction Award Plan Document

		
	I.
	PURPOSE

The Signature Office REIT, Inc. Retention and Transaction Award Plan (the “Plan”) establishes guidelines for rewarding eligible employees for their contribution towards the success of the Company closing a Transaction (as hereinafter defined) and their continued employment with the Company through the Closing Date (as hereinafter defined).  The purpose of the Plan is to incentivize and motivate eligible employees to assist the Company in the successful completion of a Transaction and to remain continuously employed by the Company through the Closing Date thereof.  The awards described herein are discretionary.  Actual payouts under the Plan will be determined in the sole discretion of the Compensation Committee.  The Company is not obligated to make any payment under this Plan.    
		
	II.
	DEFINITIONS

The following words and phrases used in the Plan shall have these meanings:
“Award Agreement Letter” means a letter agreement with an employee setting forth the terms and conditions for the payment of a Transaction Award under this Plan in a form determined by the Compensation Committee.
“Award Pool” means an amount up to $2,200,000 as determined by the Compensation Committee in its sole discretion.
“Closing Date” means the closing date of a Transaction.
“Code” means the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.
“Company” means Signature Office REIT, Inc. and its subsidiaries.
“Compensation Committee” means the Compensation Committee of the Board of Directors of the Company.
“Effective Date” means November 21, 2014, the date the Plan was approved by the Compensation Committee and the Board of Directors of the Company.
“Participant” means any full-time or part-time salaried employee of the Company who qualifies for participation in the Plan in accordance with Section IV hereof and who has received, executed and delivered back to the Company an Award Agreement Letter.
“Plan” means the Signature Office REIT, Inc. Retention and Transaction Award Plan, as amended from time to time.  
“Termination for Cause” means an employee’s termination of employment on account of any action or inaction by the employee, including: (a) any form of theft from the Company or from any employee, agent, or representative of the Company; (b) dishonesty or fraud with respect to a material matter that involves the Company; (c) insubordination; (d) failure to comply with written policies or directives of the Company, including an employment contract between the employee and the Company; (e) engaging in persistent insobriety; (f) an act of violence by the employee or the 

2

employee’s threatening violence; (g) indictment on or conviction of a felony; and (h) the employee’s failure to meet any job performance or attendance standards imposed by the Company.
“Transaction” means a transaction approved by the Board of Directors pursuant to which (a) any person or entity becoming the beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the total voting power of all of the Company’s then outstanding voting securities; or (b) a sale of all or substantially all of the assets of the Company.
“Transaction Award” means the percentage of the Award Pool allocated to a Participant as determined by the Compensation Committee, in its sole discretion, and set forth in an Award Agreement Letter.
		
	III.
	ADMINISTRATION

The Plan shall be administered by the Compensation Committee.  Prior to the Closing Date of a Transaction, the Compensation Committee shall have the power to: (a) designate eligible Participants; (b) amend the Plan; and (c) make all other determinations and take all other actions necessary or desirable for the Plan’s administration.
		
	IV.
	ELIGIBILITY FOR PARTICIPATION

		
	A.
	General Provision 

All full-time or part-time salaried employees may be eligible to participate in the Plan effective with the first day of employment.  
Except for Participants described in Section IV.B. below, a Participant must be continuously employed as a full-time or part-time employee of the Company from the later of the Effective Date and the first day of such employee’s employment with the Company through the Closing Date.  If a Participant does not remain continuously employed as a full-time or part-time employee of the Company through the Closing Date and such Participant does not qualify for the exception detailed in Section IV.B. below, then such Participant shall not receive a Transaction Award under the Plan.  
For example, if the Closing Date occurs at the end of the Company’s fiscal year, any Participant who terminated employment during such year generally would not be entitled to receive a Transaction Award.  However, if the Compensation Committee had approved a Transaction Award in accordance with Section VI hereof, and such Participant was described in Section IV.B. below, then such Participant would be entitled to receive a Transaction Award. 
		
	B.
	Exception for Certain Participants

This Section IV.B. is an exception to the general rule found in Section IV.A. that a Participant must be continuously employed as a full-time or part-time employee of the Company through the Closing Date.  If the Compensation Committee determines, in accordance with Section VI, that a Transaction Award will be paid to Participants, this Section IV.B. permits payment of such Transaction Award to the following classes of Participants (hereinafter referred to as “Section IV.B. Participants”) who are not continuously employed as full-time or part-time employees of the Company through the Closing Date: 

3

		
	(i) 
	Participants whose employment terminates by reason of active duty military service; 

		
	(ii) 
	Participants whose employment terminates because of death; or

		
	(iii) 
	Participants whose employment terminates because of disability.

If the Section IV.B. Participant is not continuously employed as a full-time or part-time employee of the Company through the Closing Date, then such Participant may receive a prorated Transaction Award.  If the Compensation Committee approves a Transaction Award in accordance with Section VI hereof, the prorated amount of such Transaction Award will be determined by the Compensation Committee in its sole discretion.
Any Transaction Award allowed under this Section IV.B. will be paid at the same time and in the same form as the date and form for payment set forth in Section VI hereof. 
		
	C.
	No Transaction Award Payment if Employee is Terminated for Cause or Commits an Immediately Dismissible Offense

If the Compensation Committee approves a Transaction Award in accordance with Section VI hereof, but a Participant’s employment is terminated on or before the Closing Date (i) as a result of a Termination for Cause; or (ii) for any immediately dismissible offense, then no Transaction Award will be paid, unless otherwise required by law.  For actions that result in immediate dismissal, please refer to the Employee Handbook:  Section IV – Business Standards / Code of Conduct / General Policies, Subsection L. – Discipline.
		
	V.
	DETERMINATION OF TRANSACTION AWARDS

The Award Pool will be allocated among the Participants as determined by the Compensation Committee, in its sole discretion, and each Transaction Award approved by the Compensation Committee based on such allocation shall be set forth in an Award Agreement Letter.
		
	VI.
	DISCRETIONARY PAYMENT OF TRANSACTION AWARDS

		
	A.
	Obligations of Company 

Notwithstanding any other provision in this Plan to the contrary, the Company is not obligated to make any Transaction Award or pay any Transaction Award pursuant to this Plan.  The provisions of this Plan are merely a guideline for the Compensation Committee in determining whether, and in what amount, if any, a Transaction Award may be paid under this Plan.
		
	B.
	When Awards are Earned 

No Transaction Award is earned until the Closing Date.  Furthermore, the Compensation Committee may determine the amount of a Transaction Award and declare that such Transaction Award will be payable upon the closing of the Transaction for one or more Participants and not for other Participants.

4

		
	C.
	When Awards are Paid 

If the Compensation Committee determines that a Transaction Award will be paid to a Participant, then payment of such Transaction Award shall be made no later than five business days following the Closing Date.  Each such Transaction Award shall be made in the form of a lump-sum cash payment.  
		
	VII.
	LIMITATIONS

Any Transaction Award described in this Plan is not earned by any Participant until the Compensation Committee declares that such Transaction Award shall be paid, the Compensation Committee determines the amount of the Transaction Award, the Company enters into an Award Agreement Letter with the Participant and the closing of the Transaction occurs.  The Compensation Committee is the final authority for administration and interpretation of this Plan, and each determination by the Compensation Committee shall be binding and conclusive for all purposes.
Nothing in the Plan, or in any notice of award or Award Letter Agreement made pursuant to the Plan, shall confer upon any person the right to continue in the employment of the Company, nor affect the Company’s right to terminate the employment of any person.
		
	VIII.
	TERM OF THE PLAN

The Plan shall continue and be in effect, at the discretion of the Compensation Committee, until all Transaction Awards, if any, are paid following the Closing Date.
		
	IX.
	EFFECTIVE DATE

This Plan, as may be amended from time to time, shall be effective as of the Effective Date. 
		
	X.
	AMENDMENTS

The Compensation Committee may amend, suspend or terminate this Plan at any time.
		
	XI.
	MISCELLANEOUS

Nothing in this Plan shall prevent or limit a Participant’s continuing or future participation in any benefit, bonus, incentive or other plan or program provided by the Company, nor shall anything herein limit or reduce such rights as the Participant may have under any other agreements with the Company.
No benefits payable under the Plan will be subject to the claim or legal process of any creditor of any Participant or beneficiary, and no Participant or beneficiary will alienate, transfer, anticipate or assign any benefits under the Plan, except that distributions will be made pursuant to judgments resulting from federal tax assessments. 
All payments made by the Company under this Plan shall be net of any tax or other amounts required to be withheld by the Company under any applicable law or legal requirement.
The headings and subheadings in this Plan have been inserted primarily for convenient reference. In the event any heading or subheading conflicts with the context, the context will govern.  This 

5

Plan will be construed in accordance with the laws of the State of Georgia, except to the extent such laws are preempted by the Code. 

6Consulting Agreement

 

THIS AGREEMENT (the “Agreement”),
is effective dated as of November 1st 2014, by and between Amarantus BioScience Holdings, Inc., a Nevada corporation
(the “Company”), and NeuroAssets SARL, a company registered in Vevey, Switzerland (the "Consultant)
This Agreement runs concurrently with the Agreement dated November 1st 2013 between Company and Consultant and does
not replace it.

 

W I T N E S S E T H:

 

WHEREAS, the Company desires to
retain, and has retained, the Consultant and the Consultant desires to be retained by, and has been retained by, the Company pursuant
to the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual promises and covenants herein contained, it is hereby agreed as follows:

 

Section 1. RETENTION and TERM.

 

		(a)	The Company hereby retains, and has retained, the Consultant on an
non-exclusive basis from the effective date to perform the services set forth in Section 1(b), commencing on the date hereof, and
the Consultant hereby accepts, and has accepted, such retention and shall perform for the Company the duties described herein,
faithfully and to the best of the Consultant’s ability. David A. Lowe, PhD shall be
responsible for the quality of the services provided by NeuroAssets, SARL to fulfill the terms of this Agreement. 

 

		(b)	The Consultant shall serve, and has served, in the following fields: gathering and processing of
scientific literature and information relating to molecules and molecular mechanisms pursued by the Company; sourcing and due diligence
of new programs for acquisition and/or licensing by the Company; preclinical and clinical development of the Company programs;
performance of experimental, developmental, or research work relating to molecules and molecular mechanisms pursued by the Company;
assistance with intellectual property filings and prosecutions, including the creation of additional inventions; assisting the
CEO with fund raising, mergers, acquisitions and licensing activities; grant and other non-dilutive funding acquisition; strategic
and operational advice to the CEO; and render such advice and services to the Company as may be reasonably requested by the Company
(the "Services").

 

		(c)	The term of the consultancy shall begin on the November 1st 2014, and terminate on October
31st 2015. The term may be shortened, extended or modified by mutual written agreement between the Consultant and the
Company.

 

		(d)	The Consultant shall provide its own office and equipment and cover all associated overhead costs
including telecommunications, human resources costs, (Swiss Federal taxes, insurances, etc.), and its own secretarial support.

 

		(e)	Consultant will provide the Services by directing its employee, David A. Lowe, PhD, devote 60%
of his business time to performing such Services. While providing the Services, David A. Lowe, PhD shall assume the role of President
Amarantus Europe.

 

 

Section 2. COMPENSATION.

 

		a)	In consideration for the Consultant providing the Services described above, the Company shall compensate
the Consultant at the monthly rate of seventeen thousand and two hundred and fifty (17,250)US Dollars. The compensation shall be
due and payable the fifteenth (15th) of each calendar month commencing with the effective date upon execution of this
agreement.

		b)	A success bonus of USD 60,000 shall be payable when the Company is uplisted from OTC to NYSE or
NASDAQ.

 

    	Page 1

    	 

    

 

		c)	Except as otherwise provided for herein, all fees due to the Consultant hereunder are non-refundable,
non-cancelable and shall be free and clear of any and all encumbrances

 

 

Section 3. EXPENSES.

The Company shall reimburse the Consultant
for all pre-approved (in advance and in writing) out-of-pocket expenses incurred by the Consultant in connection with its duties
hereunder with respect to the Company. Such expenses shall include travel, associated hotel accommodation and sustenance. Any such
expenses shall be evidenced by written documentation prior to reimbursement. Reimbursement by the Company to the Consultant, or
to any third party designated by the Consultant, shall be made within 30 days of presentation of expenses to the Company by the
Consultant. Consultant shall travel business class on any flights lasting more than five (5) hours, and in first class on train
journeys. The Consultant shall make its own travel arrangements unless the Company prefers to do so.

 

Section
4. TERMINATION. Either party may terminate this Agreement at any time for any reason or no reason by
providing sixty (60) days prior written notice thereof; however, such termination shall not remove the Company’s nor the
Consultant’s obligations that survive per the terms of the Agreement, including, but not limited to, the Company’s
obligation to pay Compensation already earned by the Consultant according to Section 2 and 3 of this contract. 

Section 5. CONFIDENTIAL INFORMATION.
The Consultant agrees that during and after the term of this Agreement, it shall keep in strictest confidence, and shall not disclose
or make accessible to any other person, except those under the same confidentiality terms as described herein, without the written
consent of the Company, the Company’s products, services and technology, both current and under development, promotion and
marketing programs, lists, trades secrets and other confidential and proprietary business information of the Company of or any
of its clients and third parties including, without limitation, Proprietary Information and Work Product (as defined in Section
6) (all of the foregoing is referred to herein as the “Confidential Information”). The Consultant agrees
(a) not to use any such Confidential Information for himself or others; and (b) not to take any such material or reproductions
thereof from the Company’s facilities at any time except, in each case, as required in connection with the Consultant’s
duties hereunder. Notwithstanding the foregoing, the parties agree the Consultant is free to use (a) information in the public
domain not as a result of a breach of this Agreement, (b) information lawfully received form a third party who had the right to
disclose such information and (c) the Consultant’s own independent skill, knowledge, know-how and experience to whatever
extent and in whatever way it wishes, in each case consistent with its obligations as the Consultant and that, at all times, the
Consultant is free to conduct any research relating to the Company’s business.

 

The Company agrees that during the term
and after this Agreement it shall not disclose in a press release the Consultant’s engagement with the Company, without the
written consent of the Consultant.

 

Section 6. OWNERSHIP OF PROPRIETARY
INFORMATION. 

 

		(a)	The Consultant agrees that all information that has been created, discovered or developed by the
Company, its subsidiaries, affiliates, licensors, licensees, successors or assigns (collectively, the “Affiliates”)
(including, without limitation, information relating to the development of the Company’s business created, discovered, developed
by the Company any of its affiliates during the term of this Agreement, and information relating to the Company’s customers,
suppliers, advisors, and licensees) and/or in which property rights have been assigned or otherwise conveyed to the Company or
the Affiliates, shall be the sole property of the Company or the Affiliates, as applicable, and the Company or the Affiliates,
as the case may be, shall be the sole owner of all patents, copyrights and other rights in connection therewith, including, without
limitation, the right to make application for statutory protection. All the aforementioned information is hereinafter called “Proprietary
Information.” By way of illustration, but not limitation, Proprietary Information includes trade secrets, processes,
discoveries, structures, inventions, designs, ideas, works of authorship, copyrightable works, trademarks, copyrights, formulas,
improvements, inventions, product concepts, techniques, marketing plans, merger and acquisition targets, strategies, forecasts,
blueprints, sketches, records, notes, devices, drawings, customer lists, patent applications, continuation applications, continuation-in-part
applications, file wrapper continuation applications and divisional applications and information about the Company’s Affiliates,
its employees and/or advisors (including, without limitation, the compensation, job responsibility and job performance of such
employees and/or advisors).

 

    	Page 2

    	 

    

 

		(b)	The work product (“Work Product”) produced by Consultant or its employees under
this Agreement or related to this Agreement and all proprietary rights therein shall be and are the property of Company. Work Product
includes, but is not limited to inventions, discoveries, compounds, reports, memoranda, drawings, computer programs, devices, models,
or other materials of any nature, or information relating to any of the foregoing, which are or were generated in connection with
the Services described in this Agreement, including the Schedule A attached hereto. Consultant will assign and does hereby assign
to Company all patents, copyrights, trademarks and trade secrets conceived or reduced to practice which are Work Product pursuant
to this Agreement. Notwithstanding the foregoing, Company makes no claim of ownership to pre-existing technology owned by Consultant
prior to October 1, 2012, except that Consultant grants a non-exclusive, royalty free right to use such technology in association
with the Work Product. Consultant will cooperate with Company in the enforcement and perfection of Company’s rights. All
original content, proprietary information, trademarks, copyrights, patents or other intellectual property created by the Consultant
that is not Work Product, shall be the sole and exclusive property of the Consultant.

 

		(c)	Consultant’s Employees. Consultant shall have a written agreement with each of its employees
who will be exposed to the Proprietary Information requiring them to comply with Consultant’s obligations with respect to
Proprietary Information. Furthermore, Consultant shall have written agreements with each of its employees to enable the Consultant
to effect its obligations regarding assignment of Work Product described in Section 6(b). Consultant shall not solicit the services
of or offer employment to any person who is (or was during the prior twelve months) an employee of Company.

 

Section 7. NOTICES. Any notice or
other communication under this Agreement shall be in writing and shall be deemed to have been duly given: (a) by email and email
attachment(s) with confirmed acknowledgement to the respective email addresses of the Company and the Consultant; (b) when delivered
personally against receipt therefore; (c) one day after being sent by Federal Express or similar overnight delivery; or (d) five
(5) business days after being mailed registered or certified mail, postage prepaid.

 

Section 8. STATUS OF CONSULTANT.
The Consultant shall be deemed to be an independent contractor and, except as expressly provided or authorized in the Agreement,
shall have no authority to act for or on behalf of or represent the Company, unless agreed to by separate written agreement. This
Agreement does not create a partnership or joint venture.

 

Section 9. OTHER ACTIVITIES OF CONSULTANT.
The Company recognizes that the Consultant now renders and may continue to render consulting and other services to other companies
that may or may not conduct business and activities similar to those of the Company.

 

Section 10. SUCCESSORS AND ASSIGNS.
This Agreement and all of the provisions hereof shall be binding upon and inure to benefit of the parties hereto and their
respective successors and permitted assigns. This Agreement and any of the rights, interest or obligations hereunder may be assigned
by the Consultant without the prior written consent of the Company. This Agreement and any of the rights, interests or obligations
hereunder may not be assigned by the Company without the prior written consent of the Consultant.

 

Section 11. SEVERABILITY OF PROVISIONS.
If any provision of this Agreement shall be declared by a court of competent jurisdiction to be invalid, illegal or incapable
of being enforced in whole or in part, the remaining conditions and provisions or portions thereof shall nevertheless remain in
full force and effect and enforceable to the extent they are valid, legal and enforceable, and no provision shall be deemed dependent
upon any other covenant or provision unless so expressed herein.

 

Section 12. ENTIRE AGREEMENT; MODIFICATION.
This Agreement contains the entire agreement of the parties relating to the subject matter hereof, and the parties hereto have
made no agreements, representations or warranties relating to the subject matter of this Agreement which are not set forth herein.
No amendment or modification of this Agreement shall be valid unless made in writing and signed by each of the parties hereto.

 

    	Page 3

    	 

    

 

Section 13. NON-WAIVER. The failure
of any party to insist upon the strict performance of any of the term, conditions and provisions of this Agreement shall not be
construed as a waiver or relinquishment of future compliance therewith; and the said terms, conditions and provisions shall remain
in full force and effect. No waiver of any term or condition of the Agreement on the party of any party shall be effective for
any purpose whatsoever unless such waiver is in writing and signed by such party.

 

Section 14. REMEDIES FOR BREACH.
The Consultant and The Company mutually agree that any breach of Sections 2, 4, 5, or 6 of this Agreement by the Consultant or
the Company may cause irreparable damage to the other party and/or their affiliates, and that monetary damages alone would not
be adequate and, in the event of such breach or threat of breach, the damaged party shall have, in addition to any and all remedies
at law and without the posting of a bond or other security, the right to an injunction, specific performance or other equitable
relief necessary to prevent or redress the violation of either party’s obligations under such Sections. In the event that
an actual proceeding is brought in equity to enforce such Sections, the offending party shall not urge as a defense that there
is an adequate remedy at law nor shall the damaged party be prevented from seeking any other remedies that may be available to
it. The defaulting party shall pay all attorneys’ fees and costs incurred by the other party in enforcing this Agreement.

 

Section 15. GOVERNING LAW. The parties
hereto acknowledge that the transactions contemplated by this Agreement bear a reasonable relation to the State of Nevada. This
Agreement shall be governed by, and construed and interpreted in accordance with, the internal laws of the State of Nevada without
regard to such state’s principles of conflicts of laws. The parties irrevocably and unconditionally agree that the exclusive
place of jurisdiction for any action, suit or proceeding (“Actions”) relating to this Agreement shall be
in the state and/or federal courts situated State of Nevada. Each party irrevocably and unconditionally waives any objection
it may have to the venue of any Action brought in such courts or to the convenience of the forum. Final judgment in any such Action
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment, a certified or true copy of which shall
be conclusive evidence of the fact and the amount of any indebtedness or liability of any party therein described. Service of the
process in any Action by any party may be made by serving a copy of the summons and complaint, in addition to any other relevant
documents, by commercial overnight courier to any other party at their address set forth in this Agreement.

 

Section 16. HEADINGS. The headings
of the Sections are inserted for convenience of reference only and shall not affect any interpretation of this Agreement.

 

Section 17. COUNTERPARTS. This Agreement
may be executed in counterpart signatures, each of which shall be deemed an original, but all of which, when taken together, shall
constitute one and the same instrument, it being understood that both parties need not sign the same counterpart. In the event
that any signature is delivered by email transmission of scanned attachments, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such emailed
signature page were an original thereof.

 

    	Page 4

    	 

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Agreement as of the day and year first written above.

 

Amarantus Bioscience Holdings, Inc.

 

 

 

By: __/s/ Gerald Commissiong_____________________

Name: Gerald Commisiong

Title: President &
CEO

Email: gerald@amarantus.com

 

Amarantus Bioscience Holdings, Inc.

655 Montgomery Street

Suite 900

San Francisco, CA 94111

United States of America

 

NeuroAssets SARL

 

 

 

__/s/ David
A. Lowe__________________________

Name: David A. Lowe

Title: President & CEO

Email: david.lowe@neuroassets.com

 

NeuroAssets SARL

Rue du Lac 43

CH-1800 VEVEY

Switzerland

 

    	Page 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]